5 things to know about Baxalta after Shire’s $30.6 billion bid
August 05, 2015 at 16:04 PM EDT
Baxalta makes drugs to treat rare diseases, like hemophilia, the blood disorder suffered by Russian Tsar Nicholas II’s son Alexei.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.